Zhengye Biotechnology Holding Limited Revenue from Contract with Customer, Including Assessed Tax
Zhengye Biotechnology Holding Limited (ZYBT) reported Revenue from Contract with Customer, Including Assessed Tax of CNY 116.36 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-04-28
CNY
| Period end | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|
| 2025-12-31 | 116.36M CNY 20-F · filed 2026-04-28 | |
| 2025-06-30 | 62.33M CNY 6-K · filed 2025-12-12 | |
| 2024-12-31 | 186.36M CNY 20-F · filed 2026-04-28 | |
| 2024-06-30 | 94.95M CNY 6-K · filed 2025-12-12 | |
| 2023-12-31 | 211.65M CNY 20-F · filed 2026-04-28 |
USD
| Period end | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|
| 2025-12-31 | $16.64M 20-F · filed 2026-04-28 | |
| 2025-06-30 | $8.70M 6-K · filed 2025-12-12 |